Del Río M - Search Results

1

FPR2 DNA Aptamers for Targeted Therapy of Wound Repair.

de Arriba MDC, Fernández G, Chacón-Solano E, Mataix M, Martínez-Santamaría L, Illera N, Carrión-Marchante R, Martín ME, Larcher F, González VM, Del Río M, Carretero M. de Arriba MDC, et al. Among authors: del rio m. J Invest Dermatol. 2022 Aug;142(8):2238-2248.e8. doi: 10.1016/j.jid.2021.12.026. Epub 2022 Jan 1. J Invest Dermatol. 2022. PMID: 34979109 Free article.

2

Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.

del Rio M, Sunkel C, Larcher F, Ortega MP. del Rio M, et al. Br J Pharmacol. 1997 Apr;120(7):1360-6. doi: 10.1038/sj.bjp.0701035. Br J Pharmacol. 1997. PMID: 9105713 Free PMC article.

3

A cutaneous gene therapy approach to human leptin deficiencies: correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts.

Larcher F, Del Rio M, Serrano F, Segovia JC, Ramírez A, Meana A, Page A, Abad JL, González MA, Bueren J, Bernad A, Jorcano JL. Larcher F, et al. Among authors: del rio m. FASEB J. 2001 Jul;15(9):1529-38. doi: 10.1096/fj.01-0082com. FASEB J. 2001. PMID: 11427484

4

Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.

Garcia M, Fernandez-Garcia NI, Rivas V, Carretero M, Escamez MJ, Gonzalez-Martin A, Medrano EE, Volpert O, Jorcano JL, Jimenez B, Larcher F, Del Rio M. Garcia M, et al. Among authors: del rio m. Cancer Res. 2004 Aug 15;64(16):5632-42. doi: 10.1158/0008-5472.CAN-04-0230. Cancer Res. 2004. PMID: 15313901

5

Current approaches and perspectives in human keratinocyte-based gene therapies.

Del Rio M, Gache Y, Jorcano JL, Meneguzzi G, Larcher F. Del Rio M, et al. Gene Ther. 2004 Oct;11 Suppl 1:S57-63. doi: 10.1038/sj.gt.3302370. Gene Ther. 2004. PMID: 15454958 Review.

6

A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides.

Carretero M, Del Río M, García M, Escámez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F. Carretero M, et al. Among authors: del rio m. FASEB J. 2004 Dec;18(15):1931-3. doi: 10.1096/fj.04-1515fje. Epub 2004 Sep 29. FASEB J. 2004. PMID: 15456737

7

An in vivo model of wound healing in genetically modified skin-humanized mice.

Escámez MJ, García M, Larcher F, Meana A, Muñoz E, Jorcano JL, Del Río M. Escámez MJ, et al. Among authors: del rio m. J Invest Dermatol. 2004 Dec;123(6):1182-91. doi: 10.1111/j.0022-202X.2004.23473.x. J Invest Dermatol. 2004. PMID: 15610532 Free article.

8

Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance.

Rico L, Del Rio M, Bravo A, Ramirez A, Jorcano JL, Page MA, Larcher F. Rico L, et al. Among authors: del rio m. Endocrinology. 2005 Oct;146(10):4167-76. doi: 10.1210/en.2005-0156. Epub 2005 Jun 30. Endocrinology. 2005. PMID: 15994350

9

Skin gene therapy for acquired and inherited disorders.

Carretero M, Escámez MJ, Prada F, Mirones I, García M, Holguín A, Duarte B, Podhajcer O, Jorcano JL, Larcher F, Del Río M. Carretero M, et al. Among authors: del rio m. Histol Histopathol. 2006 Nov;21(11):1233-47. doi: 10.14670/HH-21.1233. Histol Histopathol. 2006. PMID: 16874666 Review.

10

Modeling normal and pathological processes through skin tissue engineering.

Garcia M, Escamez MJ, Carretero M, Mirones I, Martinez-Santamaria L, Navarro M, Jorcano JL, Meana A, Del Rio M, Larcher F. Garcia M, et al. Among authors: del rio m. Mol Carcinog. 2007 Aug;46(8):741-5. doi: 10.1002/mc.20327. Mol Carcinog. 2007. PMID: 17610222 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

592 results

Search Page